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EDITORIAL 
Antibiotic resistant strains and species referred to as ‘’super bugs’’ contribute to 
emergence of disease. Antibiotic resistant bacterial infections have become a threat, 
in particular in developing countries. Incidence and mortality from infectious 
diseases have increased during the past decade. Antibiotic resistance causes 
biological cost by reducing fitness of resistant strains, which can minimize the 
spread of resistant bacteria. Additional mutations also aid in the survival of resistant 
bacteria (Topp et al., 2013). Microbes that are resistant to multiple antimicrobials are 
called multidrug resistant (MDR) (Iqbal et al., 2015a). Antibiotics are among the most 
commonly prescribed drugs in hospitals and in developed countries about 30% of 
the hospitalized patients are treated with these drugs (Shankar et al., 2003). 
In this issue, Saleem et al. report the Ceftazidime resistance in clinical isolates of 
bacteria. The proportions of resistant isolates to Ceftazidime ranged E.coli 56.31%, 
Staphylococcus aureus 6.84%, Pseudomonas aeruginosa 4.21%, Klebsiella 1.57%, 
and Proteus sp. 1.05%. Our data showed that female patients had the highest level 
of resistant bacteria compared to males. That significantly more resistant bacteria 
were found in female clinical samples correlates with a higher susceptibility of 
infection in females than males, due to the physiological and anatomical differences. 
Ceftazidime is a third-generation cephalosporin that was introduced into clinical use 
in the 1980s because of its verified broad spectrum activity against Gram-positive 
cocci and Gram-negative bacilli, including Pseudomonas aeruginosa (Turner, 2009). 
The emergence of Ceftazidime-resistant bacteria must be considered one of the 
most frightening consequences of microbial evolution in the last 2 decades. The 
physicians prescribe broad spectrum antibiotics without antibiotic susceptibility test. 
There is no systematic national surveillance of antibiotic resistance and insufficient 
data is available to quantify the problem (Abdul et al., 2008). Resistance to 
Ceftazidime demonstrated that more consumption of a specific antibiotic leads to 
sustainability of resistance against it. These resistant isolates can be further studied 
in terms of their multidrug resistance and resistance to other antibiotics to find a 
suitable antibiotic or combinations of antibiotics for the treatment of infectious 
diseases. Plant derived products can be tested to determine antibacterial activity 
(Hussain et al., 2016; Iqbal et al., 2015b; Shahzad et al., 2017) that can be used to 
treat infectious diseases. 
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Although well conducted, there are some limitations to 
the present work. The molecular methods can be employed 
to detect antibiotic resistance. Moreover, the types of 
bacteria tested were limited to 5 strains. More attention is 
needed to recognize and measure trends in resistance 
internally. There is an immediate need to step out and 
control these pathogenic infections and lest effectiveness of 
antibiotics. 
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